日本高潮视频在线观看-亚洲中文字幕永不卡-精品亚洲一区二区三区-伦理片夜夜躁狠狠躁日日躁-日本最新免费不卡二区-国产精品口爆一区二区三区-av一区二区三区高清-大鸡巴疯狂抽插小穴视频-日韩中文国产在线观看免费视频

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Saimiri boliviensis boliviensis Caspase-3 (CASP3) CSB-YP711391SWC
CSB-EP711391SWC
CSB-BP711391SWC
CSB-MP711391SWC
CSB-EP711391SWC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycobacterium vanbaalenii Lanosterol 14-alpha demethylase (cyp51) CSB-YP711392MOQ
CSB-EP711392MOQ
CSB-BP711392MOQ
CSB-MP711392MOQ
CSB-EP711392MOQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Beta vulgaris Maturase K (matK), partial CSB-YP711393BSQ
CSB-EP711393BSQ
CSB-BP711393BSQ
CSB-MP711393BSQ
CSB-EP711393BSQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Froelichia floridana Maturase K (matK), partial CSB-YP711394FAAP
CSB-EP711394FAAP
CSB-BP711394FAAP
CSB-MP711394FAAP
CSB-EP711394FAAP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rat Vomeronasal type-1 receptor A15 (V1ra15), partial CSB-YP711395RA1
CSB-EP711395RA1
CSB-BP711395RA1
CSB-MP711395RA1
CSB-EP711395RA1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rat Vomeronasal type-1 receptor A13 (V1ra13), partial CSB-YP711396RA1
CSB-EP711396RA1
CSB-BP711396RA1
CSB-MP711396RA1
CSB-EP711396RA1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella choleraesuis UPF0401 protein yubL (yubL) CSB-YP711397SBF
CSB-EP711397SBF
CSB-BP711397SBF
CSB-MP711397SBF
CSB-EP711397SBF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Macaca mulatta Beta-defensin 123 (DEFB123) CSB-YP711398MOW
CSB-EP711398MOW
CSB-BP711398MOW
CSB-MP711398MOW
CSB-EP711398MOW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Trichophyton rubrum Carboxypeptidase S1 homolog B (SCPB), partial CSB-YP711399TQA
CSB-EP711399TQA
CSB-BP711399TQA
CSB-MP711399TQA
CSB-EP711399TQA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Human Membrane-spanning 4-domains subfamily A member 13 (MS4A13), partial CSB-YP711400HU1
CSB-EP711400HU1
CSB-BP711400HU1
CSB-MP711400HU1
CSB-EP711400HU1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aedes albopictus ATP synthase subunit a (mt:ATPase6), partial CSB-YP711401AXR1
CSB-EP711401AXR1
CSB-BP711401AXR1
CSB-MP711401AXR1
CSB-EP711401AXR1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pyrococcus kodakaraensis Putative ribose 1,5-bisphosphate isomerase (TK0434) CSB-YP711402FHY
CSB-EP711402FHY
CSB-BP711402FHY
CSB-MP711402FHY
CSB-EP711402FHY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pyrococcus kodakaraensis 50S ribosomal protein L23P (rpl23p) CSB-YP711403FHY
CSB-EP711403FHY
CSB-BP711403FHY
CSB-MP711403FHY
CSB-EP711403FHY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pyrococcus kodakaraensis 50S ribosomal protein L3P (rpl3p) CSB-YP711404FHY
CSB-EP711404FHY
CSB-BP711404FHY
CSB-MP711404FHY
CSB-EP711404FHY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pyrococcus kodakaraensis Preprotein translocase subunit SecG (secG), partial CSB-YP711405FHY
CSB-EP711405FHY
CSB-BP711405FHY
CSB-MP711405FHY
CSB-EP711405FHY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pyrococcus kodakaraensis V-type ATP synthase subunit I (atpI), partial CSB-YP711406FHY1
CSB-EP711406FHY1
CSB-BP711406FHY1
CSB-MP711406FHY1
CSB-EP711406FHY1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pyrococcus kodakaraensis Geranylgeranylglyceryl phosphate synthase (TK1026) CSB-YP711407FHY
CSB-EP711407FHY
CSB-BP711407FHY
CSB-MP711407FHY
CSB-EP711407FHY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pyrococcus kodakaraensis Ribonuclease P protein component 4 (rnp4) CSB-YP711408FHY
CSB-EP711408FHY
CSB-BP711408FHY
CSB-MP711408FHY
CSB-EP711408FHY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pyrococcus kodakaraensis Probable inorganic polyphosphate/ATP-NAD kinase (ppnK) CSB-YP711409FHY
CSB-EP711409FHY
CSB-BP711409FHY
CSB-MP711409FHY
CSB-EP711409FHY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pyrococcus kodakaraensis Probable chemoreceptor glutamine deamidase CheD (cheD) CSB-YP711410FHY
CSB-EP711410FHY
CSB-BP711410FHY
CSB-MP711410FHY
CSB-EP711410FHY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://m.bdspa.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>



×